🇺🇸 DIMYRISTOYL LECITHIN in United States

FDA authorised DIMYRISTOYL LECITHIN on 31 May 2002

Marketing authorisations

FDA — authorised 31 May 2002

  • Application: NDA021191
  • Marketing authorisation holder: VESSELON SPV LLC
  • Local brand name: IMAGENT
  • Indication: INJECTABLE — INTRAVENOUS
  • Status: approved

Read official source →

FDA

  • Status: approved

DIMYRISTOYL LECITHIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DIMYRISTOYL LECITHIN approved in United States?

Yes. FDA authorised it on 31 May 2002; FDA has authorised it.

Who is the marketing authorisation holder for DIMYRISTOYL LECITHIN in United States?

VESSELON SPV LLC holds the US marketing authorisation.